dactinomycin and rolipram

dactinomycin has been researched along with rolipram in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cieslinski, LB; Torphy, TJ; Zhou, HL1
Barnes, PJ; Giembycz, MA; Meja, K; Seldon, PM1
Canet, E; Cogé, F; Foissier, L; Lonchampt, M1
Alkhalaf, M; El-Mowafy, AM1

Other Studies

4 other study(ies) available for dactinomycin and rolipram

ArticleYear
Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Albuterol; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; Monocytes; Protein Kinases; Pyrrolidinones; Receptors, Adrenergic, beta; Rolipram; Tumor Cells, Cultured; Up-Regulation

1992
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Molecular pharmacology, 1995, Volume: 48, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Albuterol; Amino Acid Sequence; Atrial Natriuretic Factor; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Drug Interactions; Flurbiprofen; Humans; Isoenzymes; Leukocytes, Mononuclear; Lipopolysaccharides; Molecular Sequence Data; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Stimulation, Chemical; Time Factors; Tumor Necrosis Factor-alpha

1995
In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antigens; Asthma; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Dactinomycin; Down-Regulation; Gene Expression Regulation; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Synthesis Inhibitors; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Synthesis Inhibitors; Pyrrolidinones; RNA, Messenger; Rolipram; Spleen

1996
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
    Carcinogenesis, 2003, Volume: 24, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured

2003